These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18708697)

  • 21. Doping control analysis of methoxyphenamine using liquid chromatography-tandem mass spectrometry.
    Thevis M; Sigmund G; Koch A; Guddat S; Maurer HH; Schänzer W
    Eur J Mass Spectrom (Chichester); 2008; 14(3):145-52. PubMed ID: 18708694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of tramadol and its main metabolites in horse plasma by high-performance liquid chromatography/fluorescence and liquid chromatography/electrospray ionization tandem mass spectrometry techniques.
    De Leo M; Giorgi M; Saccomanni G; Manera C; Braca A
    Rapid Commun Mass Spectrom; 2009 Jan; 23(2):228-36. PubMed ID: 19072864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening of in vitro synthesised metabolites of 4,9,11-trien-3-one steroids by liquid chromatography mass spectrometry.
    Kuuranne T; Pystynen KH; Thevis M; Leinonen A; Schänzer W; Kostiainen R
    Eur J Mass Spectrom (Chichester); 2008; 14(3):181-9. PubMed ID: 18708698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liquid chromatography electrospray ionization tandem mass spectrometry for the detection of mesocarb abuse in horse doping.
    Appolonova SA; Baranov PA; Mesonzhnik NV; Brazhnikova DO; Rodchenkov GM
    Drug Test Anal; 2011 Oct; 3(10):717-23. PubMed ID: 21964865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventive doping control screening analysis of prohibited substances in human urine using rapid-resolution liquid chromatography/high-resolution time-of-flight mass spectrometry.
    Vonaparti A; Lyris E; Angelis YS; Panderi I; Koupparis M; Tsantili-Kakoulidou A; Peters RJ; Nielen MW; Georgakopoulos C
    Rapid Commun Mass Spectrom; 2010 Jun; 24(11):1595-609. PubMed ID: 20486255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine.
    Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nishikawa M; Nakajima K; Tsuchihashi H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):315-22. PubMed ID: 15833296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of urinary prenylamine metabolites by means of liquid chromatography-tandem mass spectrometry.
    Beuck S; Sigmund G; Koch A; Schänzer W; Pokrywka A; Kwiatkowska D; Thevis M
    Drug Test Anal; 2012 Sep; 4(9):701-16. PubMed ID: 22786790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous determination of beta-blocking agents and diuretics in doping analysis by liquid chromatography/mass spectrometry with scan-to-scan polarity switching.
    Deventer K; Van Eenoo P; Delbeke FT
    Rapid Commun Mass Spectrom; 2005; 19(2):90-8. PubMed ID: 15584083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-drug interaction and doping, part 1: an in vitro study on the effect of non-prohibited drugs on the phase I metabolic profile of toremifene.
    Mazzarino M; de la Torre X; Fiacco I; Palermo A; Botrè F
    Drug Test Anal; 2014 May; 6(5):482-91. PubMed ID: 24431005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elucidation of urinary metabolites of fluoxymesterone by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry.
    Pozo OJ; Van Thuyne W; Deventer K; Van Eenoo P; Delbeke FT
    J Mass Spectrom; 2008 Mar; 43(3):394-408. PubMed ID: 18035854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of two major urinary metabolites of the PPARdelta-agonist GW1516 and implementation of the drug in routine doping controls.
    Thevis M; Möller I; Thomas A; Beuck S; Rodchenkov G; Bornatsch W; Geyer H; Schänzer W
    Anal Bioanal Chem; 2010 Apr; 396(7):2479-91. PubMed ID: 19946680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of an electrochemically synthesised metabolite of a selective androgen receptor modulator for mass spectrometry-based sports drug testing.
    Thevis M; Lohmann W; Schrader Y; Kohler M; Bornatsch W; Karst U; Schänzer W
    Eur J Mass Spectrom (Chichester); 2008; 14(3):163-70. PubMed ID: 18708696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of oral antidiabetics and their metabolites in human urine by liquid chromatography/tandem mass spectrometry--a matter for doping control analysis.
    Thevis M; Geyer H; Schänzer W
    Rapid Commun Mass Spectrom; 2005; 19(7):928-36. PubMed ID: 15747323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-throughput screening for various classes of doping agents using a new 'dilute-and-shoot' liquid chromatography-tandem mass spectrometry multi-target approach.
    Guddat S; Solymos E; Orlovius A; Thomas A; Sigmund G; Geyer H; Thevis M; Schänzer W
    Drug Test Anal; 2011; 3(11-12):836-50. PubMed ID: 22135086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-performance liquid chromatographic method for the determination of toremifene and its major human metabolites.
    Webster LK; Crinis NA; Stokes KH; Bishop JF
    J Chromatogr; 1991 Apr; 565(1-2):482-7. PubMed ID: 1831461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doping control analysis of trimetazidine and characterization of major metabolites using mass spectrometric approaches.
    Sigmund G; Koch A; Orlovius AK; Guddat S; Thomas A; Schänzer W; Thevis M
    Drug Test Anal; 2014; 6(11-12):1197-205. PubMed ID: 24913825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introduction of HPLC/orbitrap mass spectrometry as screening method for doping control.
    Virus ED; Sobolevsky TG; Rodchenkov GM
    J Mass Spectrom; 2008 Jul; 43(7):949-57. PubMed ID: 18563856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New potential markers for the detection of boldenone misuse.
    Gómez C; Pozo OJ; Geyer H; Marcos J; Thevis M; Schänzer W; Segura J; Ventura R
    J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):239-46. PubMed ID: 22664392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARM-S4 and metabolites detection in sports drug testing: a case report.
    Grata E; Perrenoud L; Saugy M; Baume N
    Forensic Sci Int; 2011 Dec; 213(1-3):104-8. PubMed ID: 21816554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doping control analysis of tricyclic tetrahydroquinoline-derived selective androgen receptor modulators using liquid chromatography/electrospray ionization tandem mass spectrometry.
    Thevis M; Kohler M; Thomas A; Schlörer N; Schänzer W
    Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2471-8. PubMed ID: 18634123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.